￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Can erdafitinib be reimbursed by medical insurance?

2026-02-01 22:25:32

Check Details
Roflumilast tablets (Roflumilast)-DALIRESP medication instructions and dosage

2026-02-01 22:25:32

Check Details
The therapeutic efficacy and pharmacological effects of dacomitinib/dacomitinib tablets

2026-02-01 22:25:32

Check Details
What are the common adverse reactions of brigatinib/brigatinib?

2026-02-01 22:25:32

Check Details
Detailed interpretation of the drug instructions for entrectinib

2026-02-01 22:25:32

Check Details
Akatinib/Acalatinib produces high ORR in Chinese patients with R/R CLL

2026-02-01 22:25:32

Check Details
Fixed-duration ibrutinib plus venetoclax studied in first-line CLL

2026-02-01 22:25:32

Check Details
Roflumilast tablets (Roflumilast)-DALIRESP effects and efficacy

2026-02-01 22:25:32

Check Details
Is evantumumab already on the market in the country?

2026-02-01 22:25:32

Check Details
How much does a bottle of enzalutamide/enzalutamide cost in 2025?

2026-02-01 22:25:32

Check Details
The therapeutic effects and adverse reactions of Sorafenib/Nexavar

2026-02-01 22:25:32

Check Details
How effective is pemetinib/pemetinib in prolonging survival?

2026-02-01 22:25:32

Check Details
Category
相关知识